Hazem Elkady

New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and <i>in silico</i> studies

Hazem Elkady, Alaa Elwan, Hesham A. El‐Mahdy et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2021 · 122 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Design, Synthesis, Docking, DFT, MD Simulation Studies of a New Nicotinamide-Based Derivative: In Vitro Anticancer and VEGFR-2 Inhibitory Effects

Eslam B. Elkaeed, Reda G. Yousef, Hazem Elkady et al. · Molecules · 2022 · 120 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Discovery of thieno[2,3-d]pyrimidine-based derivatives as potent VEGFR-2 kinase inhibitors and anti-cancer agents

Souad A. El‐Metwally, Mohsen M. Abou-El-Regal, Ibrahim H. Eissa et al. · Bioorganic Chemistry · 2021 · 117 citations

Pharmacy, Medicinal Chemistry, Oncology +13

New quinoxaline derivatives as VEGFR-2 inhibitors with anticancer and apoptotic activity: Design, molecular modeling, and synthesis

Nawaf A. Alsaif, Mohammed A. Dahab, Mohammed M. Alanazi et al. · Bioorganic Chemistry · 2021 · 105 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Design, synthesis, and biological evaluation of new challenging thalidomide analogs as potential anticancer immunomodulatory agents

Mohamed Ayman El‐Zahabi, Helmy Sakr, Khaled El‐Adl et al. · Bioorganic Chemistry · 2020 · 103 citations

Medicine, Medicinal Chemistry, Oncology +11